Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In clinical trials, patients on Topamax showed significant improvements compared to those on a placebo, with a marked decrease in the number of binges
Samir Dalvi, MD Medical Reviewer Samir Dalvi, MD, is a board-certified rheumatologist
[PMID: 22954232] PubMed record related to this compound for laboratory literature review
Side Effects & Safety AOD-9604 has a genuinely clean safety profile based on both clinical studies and community use: Injection site reactions: Mild redness or bruising, common and temporary Headache: Reported by a minority of users in the first week, typically self-resolving Fatigue: Occasional, especially at higher doses usually resolves No significant hormonal disruption: Unlike full HGH, no thyroid, insulin, or IGF-1 concerns at standard doses AOD-9604 received GRAS (Generally Recognized As Safe) status from the FDA for use as a food ingredient during its development phase an unusual distinction that reflects its clean clinical safety data
US$ 26.37
US$ 29.92
US$ 29.29
US$ 23.45
US$ 23.56
US$ 28.67
US$ 28.43
US$ 24.45
